Our study demonstrated that ERα binds to the ERE present in the promoter regions and enhances the transcription of SLC7A11 and SLC3A2 (Fig. 4), inhibiting ferroptosis and contributing to the growth of ER+ breast cancer cells. The gene discussed is SLC3A2; the disease is breast carcinoma.